Skip to content
10-K

Annual Report

LEXICON PHARMACEUTICALS, INC. LXRX

0001062822-26-000050

← back to feed
Filed
Mar 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 4, 2026 423.68M sh
Shares Diluted FY 2025 · Dec 31, 2025 363.05M sh
Shares Diluted FY 2025 · Dec 31, 2024 320.03M sh
Shares Diluted FY 2025 · Dec 31, 2023 221.13M sh
Capex FY 2025 · Dec 31, 2025 $0
Capex FY 2025 · Dec 31, 2024 $1.03M
Capex FY 2025 · Dec 31, 2023 $470K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$67.85M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$178.78M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$161.9M
Long Term Debt FY 2025 · Dec 31, 2025 $49.41M
Long Term Debt FY 2025 · Dec 31, 2024 $100.3M
Short Term Debt FY 2025 · Dec 31, 2025 $4.6M
Short Term Debt FY 2025 · Dec 31, 2024 $0
Short Term Investments FY 2025 · Dec 31, 2025 $61.9M
Short Term Investments FY 2025 · Dec 31, 2024 $171.3M
Cash And Equivalents FY 2025 · Dec 31, 2025 $34.33M
Cash And Equivalents FY 2025 · Dec 31, 2024 $66.66M
Stockholders Equity FY 2025 · Dec 31, 2025 $107.54M
Stockholders Equity FY 2025 · Dec 31, 2024 $145.95M
Current Liabilities FY 2025 · Dec 31, 2025 $20.87M
Current Liabilities FY 2025 · Dec 31, 2024 $45.25M
Total Liabilities FY 2025 · Dec 31, 2025 $77.45M
Total Liabilities FY 2025 · Dec 31, 2024 $152.47M
Current Assets FY 2025 · Dec 31, 2025 $101.9M
Current Assets FY 2025 · Dec 31, 2024 $246.19M
Total Assets FY 2025 · Dec 31, 2025 $184.99M
Total Assets FY 2025 · Dec 31, 2024 $298.42M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.14
Eps Diluted FY 2025 · Dec 31, 2024 −$0.63
Eps Diluted FY 2025 · Dec 31, 2023 −$0.80
Eps Basic FY 2025 · Dec 31, 2025 −$0.14
Eps Basic FY 2025 · Dec 31, 2024 −$0.63
Eps Basic FY 2025 · Dec 31, 2023 −$0.80
Sga Expense FY 2025 · Dec 31, 2025 $37.32M
Sga Expense FY 2025 · Dec 31, 2024 $143.1M
Sga Expense FY 2025 · Dec 31, 2023 $113.98M
Rd Expense FY 2025 · Dec 31, 2025 $61.12M
Rd Expense FY 2025 · Dec 31, 2024 $84.48M
Rd Expense FY 2025 · Dec 31, 2023 $58.89M
Net Income FY 2025 · Dec 31, 2025 −$50.34M
Net Income FY 2025 · Dec 31, 2024 −$200.4M
Net Income FY 2025 · Dec 31, 2023 −$177.12M
Operating Income FY 2025 · Dec 31, 2025 −$48.91M
Operating Income FY 2025 · Dec 31, 2024 −$197.12M
Operating Income FY 2025 · Dec 31, 2023 −$171.75M
Cost Of Revenue FY 2025 · Dec 31, 2025 $274K
Cost Of Revenue FY 2025 · Dec 31, 2024 $616K
Cost Of Revenue FY 2025 · Dec 31, 2023 $85K